Synthesis of Pyrazoline-Dihydropyrimidinone hybrids and preliminary cytotoxic evaluation against colorectal cancer cell lines

- 342827
Abstract
Favorite this paper
How to cite this paper?
Abstract

A series of pyrazoline–dihydropyrimidinone (Pyr–DHPM) hybrid compounds was synthesized in good yields (70–86%) through a multistep synthetic route followed by the copper-catalyzed azide–alkyne cycloaddition (CuAAC) reaction,1 affording a 1,2,3-triazole linker between the two pharmacophores.2 All hybrids were fully characterized by standard spectroscopic techniques. Molecular hybridization is a well-established strategy in medicinal chemistry that enables the development of multitarget-directed agents.3 Considering the urgent need for more selective therapies against colorectal cancer,4 the cytotoxic activity of the Pyr–DHPM hybrids was evaluated in HCT-116, HCT-15, DIFI, and LoVo colorectal cancer cell lines.5 Several compounds reduced cell viability, with the most pronounced and selective effects observed in LoVo cells (29.5–45.9% viability reduction) while exhibiting lower toxicity toward non-malignant HFF-1 cells. These findings identify Pyr–DHPM hybrids as promising scaffolds for further optimization as potential colorectal anticancer agents.

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 Universidade Federal do Rio Grande do Sul
  • 2 Federal University of Rio Grande do Sul
  • 3 Hospital de Câncer de Barretos
Track
  • BMOS-2026
Keywords
Pyrazolines
Dihydropyrimidinones
Hybrids
Colorectal Cancer